In contrast, high levels of T-bet expression are associated with superior disease-specific survival (DSS) [23], suggesting that T CD8+ T-bet+ cells could be a newly identified subset of exhausted or immunodeficient T CD8+ cells that allow tumor progression in cHL. This evidence concerns the gene CD8A and neoplasm.